ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry

January 5, 1996